East Hanover, N.J., January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winter ...
Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.
Abstract: Thermal runaway is a growing concern in the field of Lithium ion batteries. To address this, temperature measurement is the most direct method. However, placing temperature sensors on each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results